PARIS (dpa-AFX) - French drug maker Sanofi (SNYNF, SNY) reported Friday a
higher profit in its first quarter, while net sales were hurt mainly by weak
results in Diabetes unit and Venezuela. Excluding Venezuela.
Aggregate Group sales increased 3...
Drugmakers are placing big bets on medicines they expect will command premium prices. Sanofi made an unsolicited, $9.3 billion offer to purchase Medivation. Separately, AbbVie agreed to pay $5.8 billion for Stemcentrx.
The French pharmaceuticals giant Sanofi has made a near-$10-billion (£6.85 billion) bid for the American biotech firm Medivation, which specialises in cancer treatments.
In a letter sent to Medivation on Thursday, Sanofi's chief executive,...
PARIS (dpa-AFX) - Medivation, Inc. (MDVN) confirmed it has received an
unsolicited, non-binding proposal from Sanofi to acquire all outstanding shares
of the company common stock for $52.50 in cash. Medivation said its stockholders
are advised to...